Valuation: Ipca Laboratories Limited

Market Cap 465B 4.9B 4.35B 4.04B 3.67B 6.93B 7.04B 48.52B 19.02B 243B 18.39B 17.99B 773B P/E 2027 *
30.7x
P/E 2028 * 26.1x
Enterprise Value 454B 4.79B 4.25B 3.94B 3.59B 6.77B 6.88B 47.4B 18.59B 237B 17.96B 17.58B 756B EV / Sales 2027 *
4.13x
EV / Sales 2028 * 3.63x
Free-Float
54.94%
Yield 2027 *
0.31%
Yield 2028 * 0.34%
1 day-4.21%
1 week-4.32%
Current month-4.90%
1 month-6.05%
3 months-3.05%
6 months+25.40%
Current year+29.16%
1 week 1,813.2
Extreme 1813.2
1,940
1 month 1,813.2
Extreme 1813.2
2,038
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,251.6
Extreme 1251.6
2,038
3 years 933.1
Extreme 933.1
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-4.21%-4.32%+42.24%+90.14% 4.9B
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.58%+2.82%+35.87%+64.50% 394.58B
Weighted average by Cap. +0.13%+3.82%+39.18%+71.46%

Financials

2027 *2028 *
Net sales 110B 1.16B 1.03B 954M 868M 1.64B 1.66B 11.47B 4.5B 57.35B 4.35B 4.25B 183B 123B 1.29B 1.15B 1.07B 969M 1.83B 1.86B 12.8B 5.02B 64.03B 4.85B 4.75B 204B
Net income 15.12B 159M 142M 131M 119M 225M 229M 1.58B 619M 7.89B 598M 585M 25.16B 17.9B 189M 168M 155M 141M 267M 271M 1.87B 732M 9.34B 708M 693M 29.77B
Net Debt -10.65B -112M -99.75M -92.45M -84.12M -159M -161M -1.11B -436M -5.56B -421M -412M -17.72B -19.96B -210M -187M -173M -158M -297M -302M -2.08B -816M -10.41B -789M -772M -33.2B
Projected Income Statement - Annual - Ipca Laboratories Limited
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-10-16 ₹1,832.60 -4.21% 215,600
26-10-15 ₹1,913.10 +0.08% 166,493
26-10-14 ₹1,911.60 -0.40% 205,496
26-10-13 ₹1,919.20 +1.02% 341,431
26-10-12 ₹1,899.90 -0.81% 175,831
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Ipca Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,832.60INR
Average target price
1,981.72INR
Spread / Average Target
+8.14%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipca Laboratories Limited
  1. Stock Market
  2. Stocks
  3. IPCALAB Stock